Pre-Market Movers: Dendreon (NASDAQ:DNDN), Arrowhead Research (NASDAQ:ARWR), Magna International Inc. (NYSE:MGA)

Shares of Dendreon (NASDAQ:DNDN) climbed in Monday’s pre-market session, after the biotechnology company reported a narrower-than-expected Q4 adjusted loss on revenue that was above Street estimates, and said it will make its Provenge prostate-cancer treatment commercially available in Germany and the U.K. Dendreon (NASDAQ:DNDN) was up 4.2% at $3 in recent pre-market trading. It has…

Read More

Monday Morning Roundup: AstraZeneca plc (NYSE:AZN), Rockwood Holdings (NYSE:ROC), The Men’s Wearhouse (NYSE:MW)

The American Depositary Receipts of AstraZeneca plc (NYSE:AZN) slipped nearly 2% in Monday’s pre-market session after the drugmaker reported that the U.S. FDA approved its Bydureon Pen (2 mg) despite a boxed warning regarding the risk of thyroid C-cell tumors in the use of Bydureon. The Bydureon Pen is an injectable suspension used as a…

Read More
FB Nasdaq FB Facebook

Stocks Making Noise After Hours: Bunge Limited (NYSE:BG), National Interstate Corp.’s (NASDAQ:NATL) , PHI Inc. (NASDAQ:PHII), KKR & Co. L.P. (NYSE:KKR), Strategic Hotels & Resorts, Inc. (NYSE:BEE)

Bunge Limited (NYSE:BG), a global agribusiness and food company, has declared a regular quarterly cash dividend of $0.30 per common share, payable June 2, 2014, to shareholders of record May 16, 2014. The company also declared a quarterly cash dividend of $1.21875 per share on its 4.875% cumulative convertible perpetual preference shares, payable June 1,…

Read More